Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: Amelioration by the antioxidant, α-lipoic acid

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 5, 2010, Pages

  Cummings, Bethany P ^a   Stanhope, Kimber L ^a   Graham, James L ^a   Evans, Joseph L ^b   Baskin, Denis G ^c,d   Griffen, Steven C ^e   Havel, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ReceptorBio   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dyslipidemia; Glucose tolerance; Islet function; Oxidative capacity

Indexed keywords

ANTIOXIDANT; FRUCTOSE; GLUCOSE; INSULIN SENSITIZING AGENT; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INCIDENCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KAPLAN MEIER METHOD; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT;

ADIPONECTIN; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DYSLIPIDEMIAS; ENERGY METABOLISM; FRUCTOSE; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERCELLULAR ADHESION MOLECULE-1; KAPLAN-MEIERS ESTIMATE; LEPTIN; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; THIOCTIC ACID; TOCOPHEROLS; TRIGLYCERIDES;

EID: 77951763073     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00468.2009     Document Type: Article

References (48)

1. Arivazhagan P, Panneerselvam SR, Panneerselvam C. Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and lipids in aged rats. J Gerontol A Biol Sci Med Sci 58: B788-B791, 2003.
2. Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism. Endocrinology 147: 4252-4262, 2006. (Pubitemid 44268376)
3. Cavarape A, Feletto F, Mercuri F, Quagliaro L, Daman G, Ceriello A. High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest 24: 838-845, 2001. (Pubitemid 34036713)
4. Cummings BP, Digitale EK, Stanhope KL, Graham JL, Baskin DG, Reed BJ, Sweet IR, Griffen SC, Havel PJ. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat. Am J Physiol Regul Integr Comp Physiol 295: R1782-R1793, 2008.
5. Davidson JK, Haist RE. A study of the levels of extractable insulin of guinea pig pancreas. Can J Physiol Pharmacol 42: 315-317, 1964.
6. Dixit PK, Lowe IP, Heggestad CB, Lazarow A. Insulin content of microdissected fetal islets obtained from diabetic and normal rats. Diabetes 13: 71-77, 1964.
7. El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 39: 303-307, 2002. (Pubitemid 34165233)
8. Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance? Indian J Med Res 125: 355-372, 2007.
9. Evans JL, Goldfine ID. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2: 401-413, 2000.
10. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003.
11. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
12. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7: 1040-1052, 2005. (Pubitemid 40967154)
13. Evans JL, Youngren JF, Goldfine ID. Effective treatments for insulin resistance: trim the fat and douse the fire. Trends Endocrinol Metab 15: 425-431, 2004.
14. Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 127: 103-107, 1997. (Pubitemid 27069024)
15. Faure P, Rossini E, Wiernsperger N, Richard MJ, Favier A, Halimi S. An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes 48: 353-357, 1999. (Pubitemid 29061110)
16. Folch J, Lees M, and Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
17. Griffen SC, Wang J, German MS. A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat. Diabetes 50: 63-68, 2001. (Pubitemid 32047982)
18. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63: 133-157, 2005.
19. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of RAC-alphalipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27: 309-314, 1999. (Pubitemid 29395422)
20. Jain SK, McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48: 1850-1855, 1999.
21. Karam JH, Grodsky GM. Insulin content of pancreas after sodium fluoroacetate-induce hyperglycemia. Proc Soc Exp Biol Med 109: 451-454, 1962.
22. Kawano K, Hirashima T, Mori S, Man ZW, Natori T. The OLETF rat. In: Animal Models of Diabetes: A Primer, edited by Sima AAF and Shafrir E. Amsterdam: Harwood Academic Publishers, 2001, p. 213-225.
23. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10: 727-733, 2004. (Pubitemid 38937638)
24. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22: 280-287, 1999. (Pubitemid 29056923)
25. Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332: 885-891, 2005.
26. Levi B, Werman MJ. Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr 128: 1442-1449, 1998. (Pubitemid 28399940)
27. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139: 551-558, 1998.
28. Packer L, Roy S, Sen CK. Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol 38: 79-101, 1997.
29. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
30. Pershadsingh HA. Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome. Expert Opin Investig Drugs 16: 291-302, 2007. (Pubitemid 46394854)
31. Poh Z, Goh KP. A current update on the use of alpha lipoic acid in the management of Type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 9: 392-398, 2009.
32. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375-380, 1964.
33. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790: 1149-1160, 2009.
34. Shen QW, Jones CS, Kalchayanand N, Zhu MJ, Du M. Effect of dietary alpha-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice. J Anim Sci 83: 2611-2617, 2005.
35. Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 66: 646-657, 2008.
36. Song KH, Lee WJ, Koh JM, Kim HS, Youn JY, Park HS, Koh EH, Kim MS, Youn JH, Lee KU, Park JY. alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. Biochem Biophys Res Commun 326: 197-202, 2005.
37. Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 87: 1194-1203, 2008.
38. Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 88: 1733S-1737S, 2008.
39. Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19: 16-24, 2008.
40. Stanhope KL, Kras KM, Moreno-Aliaga MJ, Havel PJ. A comparison of adipocyte size and metabolism in Charles River and Harlan Sprague Dawley rats (Abstract). Obesity Res 8: 66S, 2000.
41. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322-1334, 2009.
42. Stanhope KL, Sinha M, Graham J, Havel PJ. Low circulating adiponectin levels and reduced adipocyte adiponectin production in obese, insulin-resistant Sprague-Dawley rats (Abstract). Diabetes 52: A404, 2002.
43. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49: 1006-1015, 2000. (Pubitemid 30349424)
44. Swarbrick MM, Stanhope KL, Elliott SS, Graham JL, Krauss RM, Christiansen MP, Griffen SC, Keim NL, Havel PJ. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 100: 947-952, 2008.
45. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res 5: 195-200, 2004. (Pubitemid 39386567)
46. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol [B] 174: 587-592, 2004. (Pubitemid 40047512)
47. Wei Y, Wang D, Topczewski F, Pagliassotti MJ. Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. J Nutr Biochem 18: 1-9, 2007. (Pubitemid 44827722)
48. Williams DL, Schwartz MW, Bastian LS, Blevins JE, Baskin DG. Immunocytochemistry and laser capture microdissection for real-time quantitative PCR identify hindbrain neurons activated by interaction between leptin and cholecystokinin. J Histochem Cytochem 56: 285-293, 2008.